Abstract
Purpose
Evidence shows that patients with gestational diabetes mellitus (GDM) may exhibit features of dyslipidemic phenotype later in life. We aimed to examine and compare dyslipidemia incidence rate and the trend of lipid changes over a 15-years follow-up between the women with the history of GDM and their healthy peers.
Methods
This longitudinal study included 289 patients with GDM and 1183 women without GDM, aged 20–50 years. Pooled logistic regression model was utilized to estimate odds ratio of dyslipidemia. The generalized estimating equation was used to evaluate the trend of lipid parameters changes over time.
Results
Person-time dyslipidemia incidence rate in women with previous GDM was 0.067 (CI: 0.038, 0.096) with a median progression time of 2.13 years and for those without GDM was 0.059 (CI: 0.046, 0.072) with the median time of 2.31 years (\(p - valu{e_{comparison}}\) = 0.214). The generalized estimating equation (GEE) analysis revealed no significant difference in trend changes of lipid profiles between two groups.
Conclusions
Lipid disorder after GDM might be more influenced by other variables (BMI, anthropometric features, and smoking/lifestyle habits) rather than by the GDM status alone. Lipid profile changes of GDM women do not become significantly worse than their non-GDM counterparts, as time progresses.
Similar content being viewed by others
References
A. Kautzky-Willer, M. Krssak, C. Winzer, G. Pacini, A. Tura, S. Farhan, O. Wagner, G. Brabant, R. Horn, H. Stingl, B. Schneider, W. Waldhausl, M. Roden, Increased intramyocellular lipid concentration identifies impaired glucose metabolism in women with previous gestational diabetes. Diabetes 52(2), 244–251 (2003)
L. Bellamy, J.P. Casas, A.D. Hingorani, D. Williams, Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet (London, England) 373(9677), 1773–1779 (2009)
D.A. Enquobahrie, M.A. Williams, C. Qiu, D.A. Luthy, Early pregnancy lipid concentrations and the risk of gestational diabetes mellitus. Diabetes Res. Clin. Pract. 70(2), 134–142 (2005)
E.P. Gunderson, V. Chiang, M.J. Pletcher, D.R. Jacobs, C.P. Quesenberry, S. Sidney, C.E. Lewis, History of gestational diabetes mellitus and future risk of atherosclerosis in mid-life: the coronary artery risk development in young adults study. J. Am. Heart Assoc. 3(2), e000490 (2014)
E. Noctor, C. Crowe, L.A. Carmody, B. Kirwan, A. O’Dea, L.G. Glynn, B.E. McGuire, P.M. O’Shea, F.P. Dunne, ATLANTIC-DIP: prevalence of metabolic syndrome and insulin resistance in women with previous gestational diabetes mellitus by International association of diabetes in pregnancy study groups criteria. Acta Diabetol. 52(1), 153–160 (2015)
P. Chen, S. Wang, J. Ji, A. Ge, C. Chen, Y. Zhu, N. Xie, Y. Wang, Risk factors and management of gestational diabetes. Cell Biochem. Biophys. 71(2), 689–694 (2015)
A.S. Gilinsky, A.F. Kirk, A.R. Hughes, R.S. Lindsay, Lifestyle interventions for type 2 diabetes prevention in women with prior gestational diabetes: a systematic review and meta-analysis of behavioural, anthropometric and metabolic outcomes. Prev. Med. Rep. 2, 448–461 (2015)
M. Rizzo, K. Berneis, Lipid triad or atherogenic lipoprotein phenotype: a role in cardiovascular prevention? J. Atheroscler. Thromb. 12(5), 237–239 (2005)
G. Di Cianni, C. Lencioni, L. Volpe, A. Ghio, I. Cuccuru, G. Pellegrini, L. Benzi, R. Miccoli, S. Del Prato, C-reactive protein and metabolic syndrome in women with previous gestational diabetes. Diabetes/Metab. Res. Rev. 23(2), 135–140 (2007)
R.S. Padwal, A.M. Sharma, Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome. Can. J. Cardiol. 26(Suppl C), 18C–20C (2010)
H. Fadl, A. Magnuson, I. Ostlund, S. Montgomery, U. Hanson, E. Schwarcz, Gestational diabetes mellitus and later cardiovascular disease: a Swedish population based case-control study. BJOG: Int. J. Obstet. Gynaecol. 121(12), 1530–1536 (2014)
R. Cifkova, A. Krajcoviechova, Dyslipidemia and cardiovascular disease in women. Curr. Cardiol. Rep. 17(7), 609 (2015)
F. Azizi, A. Ghanbarian, A.A. Momenan, F. Hadaegh, P. Mirmiran, M. Hedayati, Y. Mehrabi, S. Zahedi-Asl, Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase II. Trials 10, 5 (2009)
F. Ramezani Tehrani, S.A. Montazeri, F. Hosseinpanah, L. Cheraghi, H. Erfani, M. Tohidi, F. Azizi, Trend of cardio-metabolic risk factors in polycystic ovary syndrome: a population-based prospective cohort study. PLoS ONE 10(9), e0137609 (2015)
F.R. Tehrani, S. Hashemi, M. Hasheminia, F. Azizi, Follow-up of women with gestational diabetes in the Tehran lipid and glucose study (TLGS): a population-based cohort study. J. Obstet. Gynaecol. Res. 38(4), 698–704 (2012)
Y. Chen, X. Zhang, B. Pan, X. Jin, H. Yao, B. Chen, Y. Zou, J. Ge, H. Chen, A modified formula for calculating low-density lipoprotein cholesterol values. Lipids Health Dis. 9, 52 (2010)
K.G. Alberti, P.Z. Zimmet, Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic Med. 15(7), 539–553 (1998)
J.R. Gavin III, K.G.M.M. Alberti, M.B. Davidson, R.A. DeFronzo, Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20(7), 1183–1197 (1997)
C. Lenfant, J.I. Cleeman, T.G. Ganiats, G. Graham, R.E. Kleinman, P. Hixon, R.C. Pasternak, G.T. Gau, H. Preuss, T.C. Peng, R.A. Jordan, L.H. Kuller, A.J. Garber, L.V. Horn, S.M. Grundy, S. Cornett, Y.D. Coble, M. Clearfield, J.M. McKenney, S. Havas, D. Vardell, K. Watson, J. Mitten, G.J. Wilson, L. Burnes-Bolton, L.T. Clark, D. Lansing, D.O. Fedder, Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285(19), 2486–2497 (2001)
K.-Y. Liang, S.L. Zeger, Longitudinal data analysis using generalized linear models. Biometrika 73(1), 13–22 (1986)
S. Brewster, B. Zinman, R. Retnakaran, J.S. Floras, Cardiometabolic consequences of gestational dysglycemia. J. Am. Coll. Cardiol. 62(8), 677–684 (2013)
J.W. Li, S.Y. He, P. Liu, L. Luo, L. Zhao, Y.B. Xiao, Association of gestational diabetes mellitus (GDM) with subclinical atherosclerosis: a systemic review and meta-analysis. BMC Cardiovasc. Disord. 14, 132 (2014)
C.M. Freire, F.B. Barbosa, M.C. de Almeida, P.A. Miranda, M.M. Barbosa, A.I. Nogueira, M.M. Guimaraes, C. Nunes Mdo, A. Ribeiro-Oliveira Jr., Previous gestational diabetes is independently associated with increased carotid intima-media thickness, similarly to metabolic syndrome - a case control study. Cardiovasc. Diabetol. 11, 59 (2012)
O. Ajala, L.A. Jensen, E. Ryan, C. Chik, Women with a history of gestational diabetes on long-term follow up have normal vascular function despite more dysglycemia, dyslipidemia and adiposity. Diabetes Res. Clin. Pract. 110(3), 309–314 (2015)
S.L. Kjos, T.A. Buchanan, M. Montoro, A. Coulson, J.H. Mestman, Serum lipids within 36 mo of delivery in women with recent gestational diabetes. Diabetes 40(Suppl 2), 142–146 (1991)
E. Koukkou, G.F. Watts, C. Lowy, Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a cross-sectional and prospective study. J. Clin. Pathol. 49(8), 634–637 (1996)
A.S. Ryan, J.C. McLenithan, G.M. Zietowski, Accelerated metabolic susceptibility to type 2 diabetes in older women with a history of gestational diabetes. Endocr. Connect. 2(2), 79–86 (2013)
A. Verma, C.M. Boney, R. Tucker, B.R.: Vohr, Insulin resistance syndrome in women with prior history of gestational diabetes mellitus. J. Clin. Endocrinol. Metabol. 87(7), 3227–3235 (2002)
C.H. Meyers-Seifer, B.R. Vohr, Lipid levels in former gestational diabetic mothers. Diabetes Care 19(12), 1351–1356 (1996)
S. Forbes, I.F. Godsland, S.D. Taylor-Robinson, J.D. Bell, E.L. Thomas, N. Patel, G. Hamilton, K.H. Parker, I. Marshall, C.D. Gray, D. Bedford, M. Caslake, B.R. Walker, D.G. Johnston, A history of previous gestational diabetes mellitus is associated with adverse changes in insulin secretion and VLDL metabolism independently of increased intrahepatocellular lipid. Diabetologia 56(9), 2021–2033 (2013)
R. Retnakaran, Y. Qi, P.W. Connelly, M. Sermer, A.J. Hanley, B. Zinman, The graded relationship between glucose tolerance status in pregnancy and postpartum levels of low-density-lipoprotein cholesterol and apolipoprotein B in young women: implications for future cardiovascular risk. J. Clin. Endocrinol. Metab. 95(9), 4345–4353 (2010)
M. Arca, G. Pigna, C. Favoccia, Mechanisms of diabetic dyslipidemia: relevance for atherogenesis. Curr. Vasc. Pharmacol. 10(6), 684–686 (2012)
M. Adiels, J. Boren, M.J. Caslake, P. Stewart, A. Soro, J. Westerbacka, B. Wennberg, S.O. Olofsson, C. Packard, M.R. Taskinen, Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia. Arterioscler. Thromb. Vasc. Biol. 25(8), 1697–1703 (2005)
B. Verges, Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes. Atherosclerosis 211(2), 353–360 (2010)
C. Capula, E. Chiefari, A. Vero, D.P. Foti, A. Brunetti, R. Vero, Prevalence and predictors of postpartum glucose intolerance in Italian women with gestational diabetes mellitus. Diabetes Res. Clin. Pract. 105(2), 223–230 (2014)
M. Barzin, S. Keihani, F. Hosseinpanah, S. Serahati, S. Ghareh, F. Azizi, Rising trends of obesity and abdominal obesity in 10 years of follow-up among Tehranian adults: Tehran lipid and glucose study (TLGS). Public Health Nutr. 18(16), 2981–2989 (2015)
Author Contributions
S.M. contributed to the manuscript writing, data analysis and critical discussion. F.R.T. contributed to the study design and execution, manuscript writing, data analysis and critical discussion. M.R. contributed to the data analysis and manuscript writing. M.A.M. contributed to the data analysis and critical discussion. F.A. contributed to the study design and execution and manuscript writing.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
All procedures performed in this study are in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Minooee, S., Ramezani Tehrani, F., Rahmati, M. et al. Dyslipidemia incidence and the trend of lipid parameters changes in women with history of gestational diabetes: a 15-year follow-up study. Endocrine 58, 228–235 (2017). https://doi.org/10.1007/s12020-017-1413-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-017-1413-3